As a result, the incentive mechanisms for generics are costly (Cour des comptes, 2014c). Re-balancing part of the current support for generics towards more payments to pharmacists for care-services such as counselling, co-ordination between care providers, patient monitoring and coaching, would reduce the dependence of their income on pharmaceutical sales and would reward their counselling function. This could be associated with further expansion of their public health-care missions, notably for following up patients with chronic diseases, as foreseen in a 2009 law (Loi hopital, patients, sante, territoires), which remains to be fully applied. The CNAMTS introduced such incentives through their pay-for-performance scheme in 2009 and enhanced them somewhat in 2012.